Epidemiological factors for type 2 diabetes mellitus: evidence from the Global Burden of Disease

Background The United Nations acknowledged diabetes as an epidemic of the 21st century. Global trends demonstrate a continuing growth in its prevalence at approximately 2.5 % per year. The aim of the study was to analyse selected epidemiological factors for type 2 diabetes mellitus in Poland, Central Europe and the World. Methods This study presents Global Burden of Disease (GBD) data. Study describes the type 2 diabetes burden in the studied populations based on years lived with disability (YLD), years of life lost (YLL), and disability-adjusted life years (DALYs). Results Type 2 diabetes has been demonstrated to be a determinant of reduced life expectancy, as in the analysed period the condition presented an increasing trend, compared to other diseases. Conclusions In recent years the observed YLL, YLD and DALY values for type 2 diabetes have been comparable to the expected ones. Thus the prognosis presented by GBD may be used as a reliable source of information and a basis for a health policy that reduces the number of patients with diabetes and related complications, comorbidities or mortality.

Automated summary

This study examines epidemiological factors of type 2 diabetes in Poland, Central Europe, and globally, finding that type 2 diabetes is a determinant of reduced life expectancy. The study analyzes Global Burden of Disease data to provide insights for health policies aimed at reducing the number of diabetes patients and related complications.